Our body receives and processes a vast number of signals. Chemical signals serve as guidance cues and ensure, for example, ...

Across multiple solid tumors, glucagon-like peptide 1 receptor agonist (GLP-1 RA) initiation after cancer diagnosis is ...

Adding these colorful, phytonutrient-packed fruits to your plate is a delicious way to offer potential protection against ...

A new PET tracer targeting carbonic anhydrase IX (CAIX) has demonstrated exceptional sensitivity and high tumor-to-background ...

Ranok Therapeutics, a clinical-stage biotechnology company developing innovative therapies, today announced positive interim Phase 1 clinical data for RNK08954, an investigational oral, selective KRAS ...

(NYSE: PFE) today announced detailed progression-free and overall survival results from Cohort 3, a randomized cohort of the Phase 3 BREAKWATER trial, evaluating BRAFTOVI ® (encorafenib) in ...

ASCO 2026 cancer breakthroughs from Chicago include daraxonrasib nearly doubling survival in metastatic pancreatic cancer, ...

A number of companies presented new data on their cancer vaccine candidates at ASCO 2026.

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of ...

Weight loss drugs were linked to a major shift in cancer survival in a new study.

At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of ...

At the world's largest cancer research meeting, new data were plentiful. But this year, there was also a focus on grief.